Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
10.14
+0.14 (1.40%)
At close: Jun 26, 2026, 4:00 PM EDT
10.07
-0.07 (-0.69%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Silence Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Silence Therapeutics stock have an average target of 32.75, with a low estimate of 4.00 and a high estimate of 75. The average target predicts an increase of 222.98% from the current stock price of 10.14.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Silence Therapeutics stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 6 | 6 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jun 24, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $75 | Buy | Reiterates | $75 | +639.64% | Jun 17, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $25 | Buy | Reiterates | $25 | +146.55% | Jun 12, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 11, 2026 |
| Chardan Capital | Chardan Capital | Buy Maintains $35 → $27 | Buy | Maintains | $35 → $27 | +166.27% | May 8, 2026 |
Financial Forecast
Revenue This Year
3.82M
from 559.00K
Increased by 583.85%
Revenue Next Year
5.52M
from 3.82M
Increased by 44.33%
EPS This Year
-0.37
EPS Next Year
4.79
from -0.37
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 18.3M | 23.9M | |
| Avg | 3.8M | 5.5M | |
| Low | 414,232 | 434,944 |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3,177.2% | 525.1% | |
| Avg | 583.9% | 44.3% | |
| Low | -25.9% | -88.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.37 | 4.79 | |
| Avg | -0.37 | 4.79 | |
| Low | -0.37 | 4.79 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.